New insider Pacitti David claimed ownership of 242,047 shares (SEC Form 3)
$AVNS
Industrial Specialties
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 04/14/2025 |
3. Issuer Name and Ticker or Trading Symbol
AVANOS MEDICAL, INC. [ AVNS ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 242,047(1) | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Performance-based restricted stock unit | 04/14/2028 | 04/14/2028 | Common Stock | 242,047(2) | $0 | D | |
| Explanation of Responses: |
| 1. Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest 30% on April 14, 2026, 30% on April 14, 2027 and 40% on April 14, 2028. Each TRSU is the economic equivalent of one share of Common Stock. |
| 2. Represents performance-based restricted share units (PRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. Such PRSUs will vest on April 14, 2028 (the PRSU Vesting Date) and will pay out: (i) at 50% of the number of PRSUs if the price of the Common Stock on the PRSU Vesting Date is $20.00; (ii) at 100% of the number of PRSUs if the price of the Common Stock on the PRSU Vesting Date is $25.00; (iii) at 200% of the number of PRSUs if the price of the Common Stock on the PRSU Vesting Date is $29.00; and (iv) at 250% of the number of PRSUs if the price of the Common Stock on the PRSU Vesting Date is $33.00 or higher. Each PRSU is the economic equivalent of one share of Common Stock. |
| Remarks: |
| /s/ Mojirade James as attorney-in-fact for David Pacitti pursuant to Power of Attorney filed herewith | 04/24/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||